Covered recipient · General Payments record
ADAM PFLUGRATH
Allopathic & Osteopathic Physicians Ophthalmology Retina Specialist
General Payments · PY2018–2024
$3,180.83
- Reported across 104 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $656.32 | 27 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Astellas Pharma US Inc | $212.09 | 4 |
| ABBVIE INC. | $197.76 | 13 |
| Regeneron Pharmaceuticals, Inc. | $53.62 | 1 |
| Tarsus Pharmaceuticals, Inc. | $49.06 | 2 |
| Oyster Point Pharma, Inc. | $46.08 | 3 |
| Thea Pharma Inc. | $26.69 | 1 |
| Genentech USA, Inc. | $24.48 | 1 |
| Alcon Laboratories Inc | $24.22 | 1 |
| Harrow Eye, LLC | $22.32 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (27)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $23.43 | 01/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105255908 | CMS |
| ABBVIE INC. | $21.25 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105255912 | CMS |
| ABBVIE INC. | $20.06 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105255916 | CMS |
| ABBVIE INC. | $25.26 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105255920 | CMS |
| ABBVIE INC. | $13.54 | 05/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105255924 | CMS |
| ABBVIE INC. | $3.74 | 06/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105255928 | CMS |
| ABBVIE INC. | $22.95 | 07/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105255932 | CMS |
| ABBVIE INC. | $4.98 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105255936 | CMS |
| ABBVIE INC. | $18.09 | 09/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105255940 | CMS |
| ABBVIE INC. | $2.52 | 10/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105255944 | CMS |
| ABBVIE INC. | $18.09 | 11/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105255948 | CMS |
| ABBVIE INC. | $20.48 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105255952 | CMS |
| ABBVIE INC. | $3.37 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105255956 | CMS |
| Alcon Vision LLC | $24.22 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110640232 | CMS |
| Astellas Pharma US Inc | $121.60 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139414463 | CMS |
| Astellas Pharma US Inc | $33.72 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139342390 | CMS |
| Astellas Pharma US Inc | $27.64 | 07/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139388634 | CMS |
| Astellas Pharma US Inc | $29.13 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139385268 | CMS |
| Genentech USA, Inc. | $24.48 | 10/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132972147 | CMS |
| Harrow Eye, LLC | $22.32 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145612332 | CMS |
| Oyster Point Pharma, Inc. | $16.00 | 01/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147418703 | CMS |
| Oyster Point Pharma, Inc. | $15.04 | 04/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147429067 | CMS |
| Oyster Point Pharma, Inc. | $15.04 | 10/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147416918 | CMS |
| Regeneron Pharmaceuticals, Inc. | $53.62 | 03/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114403697 | CMS |
| Tarsus Pharmaceuticals, Inc. | $25.61 | 02/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139124504 | CMS |
| Tarsus Pharmaceuticals, Inc. | $23.45 | 09/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139124506 | CMS |
| Thea Pharma Inc. | $26.69 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1074543967 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.